Compared with the noncancerous tissue samples, the number of NKG2D+ (a marker for the cytotoxicity of NK cells) cells distributed in the breast cancer tissues had decreased significantly (*P < 0.01 vs. the nonmalignant tissues, Figure 1B). This evidence concerns the gene KLRK1 and breast cancer.